Author:
Albers Gregory W.,Thijs Vincent N.,Wechsler Lawrence,Kemp Stephanie,Schlaug Gottfried,Skalabrin Elaine,Bammer Roland,Kakuda Wataru,Lansberg Maarten G.,Shuaib Ashfaq,Coplin William,Hamilton Scott,Moseley Michael,Marks Michael P.,
Subject
Clinical Neurology,Neurology
Reference35 articles.
1. Tissue plasminogen activator for acute ischemic stroke;The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N Engl J Med,1995
2. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials;Lancet,2004
3. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system;Zweifler;Neurology,1998
4. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study;Clark;Stroke,2000
5. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke;Clark;JAMA,1999
Cited by
1088 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献